$6.53
0.33[5.32%]
At close: Apr 23
$6.53
0[0.00%]
After Hours: 4:05PM EDT
ADMA Biologics
(NASDAQ:ADMA)ADMA Biologics Stock (NASDAQ:ADMA), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/28/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $330.00M | — | $315.30M | Get Alert |
| 02/28/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $380.00M | — | — | Get Alert |
| 01/08/2024 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $256.00M | $258.00M | $252.79M | Get Alert |
| 01/08/2024 | ADMA | ADMA Biologics | Q4 | 2023 | — | — | — | $72.00M | $74.00M | $68.49M | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $335.00M | — | — | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $290.00M | — | $278.40M | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $250.00M | — | $243.06M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $275.00M | — | $262.00M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $240.00M | — | $226.03M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $325.00M | — | — | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $220.00M | — | $212.36M | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | $258.84M | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $202.75M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $197.45M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $153.00M | $154.00M | $148.95M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $49.00M | $50.00M | $43.75M | Get Alert |
FAQ
What is the most recent guidance for ADMA Biologics (ADMA)?
There have been no specific sales or earnings guidance reported for ADMA Biologics in recent months.
Browse guidance and forecast on all stocks.